The PI3K/Akt/mTOR pathway is activated in pancreatic cancer by overexpression or activation of EGFR and insulin-like growth factor (IgF1R), by PTEN loss or secondary to k-ras mutation and activation of the Ras/Raf/MEK pathway. This evidence concerns the gene MAP2K7 and familial pancreatic carcinoma.